Antonio Ciampa - Concepedia

Author

Antonio Ciampa

Also Known As

A Ciampa, A. Ciampa, ANTONIO CIAMPA, Antonella Tufano, Antonio Ciampa, Ciampa, Alessandra, Elvira Grandone, Monica Vastola, Rossella Cacciola

Publications

995

Citations

H-Index

Concepts

All Affiliations

Azienda Ospedaliera S.Giuseppe Moscati Istituti Ospitalieri di Cremona Casa Sollievo della Sofferenza Azienda Ospedaliero-Universitaria Careggi Ospedale San Bortolo

About

Antonio Ciampa is an author at Azienda Ospedaliera S.Giuseppe Moscati specializing in medicine, thrombosis, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	6	182
2	Public Health	3	3	126
3	Epidemiology	2	2	103
4	Health Sciences	1	2	44
5	Emergency Medicine	1	1	23

Antonio Ciampa

Publications

475

Citations

H-Index

Page 1

	Year	Citations
Inherited Thrombophilic Risk Factors and Venous Thromboembolism Maurizio Margaglione, Vincenzo Brancaccio, Domenico De Lucia, CHEST Journal ThrombosisVenous ThrombosisCardiovascular DiseaseThrombophilic Risk FactorsHematology	2000	89
High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome PRJ Ames, Eiji Matsuura, Antonio Ciampa, Lupus	2010	56
Clinical Relevance of Nitric Oxide Metabolites and Nitrative Stress in Thrombotic Primary Antiphospholipid Syndrome Paul R. J. Ames, Joana R. Batuca, Antonio Ciampa, The Journal of Rheumatology	2010	55
Bleeding and re-thrombosis in primary antiphospholipid syndrome on oral anticoagulation Antonio Ciampa, Maurizio Margaglione, Giovanna Scenna, Thrombosis and Haemostasis	2005	49
Primary antiphospholipid syndrome: a low-grade auto-inflammatory disease? Paul R. J. Ames, Iolanda Antinolfi, Antonio Ciampa, Lara D. Veeken	2008	46
Managing anticoagulation in the COVID-19 era between lockdown and reopening phases Daniela Poli, Alberto Tosetto, Gulatiero Palareti, Internal and Emergency Medicine	2020	25
Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study Sophie Testa, Gualtiero Palareti, Cristina Legnani, Blood Advances Mas StudyPharmacotherapyThrombosisVenous ThrombosisDoac Treatment	2024	23
Ongoing Clinical Trials Joanna Clarke, Marguerite Ennis, Kathleen R. Lamborn, Neuro-Oncology Clinical Trial ManagementClinical EndpointClinical TrialsRandomized Controlled TrialMedicine	2010	22
Inherited thrombophilic risk factors in a large cohort of individuals referred to Italian thrombophilia centers: distinct roles in different clinical settings. Maurizio Margaglione, Vincenzo Brancaccio, Antonio Ciampa, PubMed	2001	21
Management of DOAC in Patients Undergoing Planned Surgery or Invasive Procedure: Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA) Position Paper Alessandro Squizzato, Daniela Poli, Doris Barcellona, Thrombosis and Haemostasis	2021	20

Page 1